P. falciparum merozoites were isolated in IC buffer and treated for 15 mins with the following at concentrations shown: 100 µM IBMX (3-isobutyl-1-methylxanthine, Calbiochem, USA), 50 µM KH7 (Calbiochem, USA), 100 µM ACTZ (acetazolamide, Sigma, USA), 20 µM DiB-cAMP (adenosine 3,5 cyclic monophosphate, N6, O2- dibutyryl sodium salt, Calbiochem, USA), 10 µM Ca2+ ionophore A23187 (Calbiochem, USA), 50 µM BAPTA-AM (Calbiochem, USA), 10 µM U73122 (Calbiochem, USA), 10 µM U73343 (Calbiochem, USA), 200 µM Epac agonist (8-pCPT-2’-O-Me-cAMP, Sigma, USA), 25 µM Epac antagonist ESI-05 (Biolog, Germany), 25 µM Epac antagonist ESI-09 (Biolog, Germany) and 50 µM geranyl geranyl transferase inhibitor, GGTI 298, which disrupts Rap1 function. Merozoites were then transferred to EC buffer (5 mM KCl, 140 mM NaCl, 1 mM MgCl2, 2 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH 7.2) followed by either measurement of cytosolic cAMP and Ca2+ levels in merozoites or microneme secretion.
Esi 05
ESI-05 is an electrochemical sensor that measures the electrical properties of a sample. It is designed to provide accurate and reliable measurements of various electrochemical parameters, such as conductivity, pH, and redox potential. The ESI-05 is a versatile piece of lab equipment suitable for a wide range of applications in various industries.
Lab products found in correlation
10 protocols using esi 05
Modulation of Malaria Merozoite Signaling
P. falciparum merozoites were isolated in IC buffer and treated for 15 mins with the following at concentrations shown: 100 µM IBMX (3-isobutyl-1-methylxanthine, Calbiochem, USA), 50 µM KH7 (Calbiochem, USA), 100 µM ACTZ (acetazolamide, Sigma, USA), 20 µM DiB-cAMP (adenosine 3,5 cyclic monophosphate, N6, O2- dibutyryl sodium salt, Calbiochem, USA), 10 µM Ca2+ ionophore A23187 (Calbiochem, USA), 50 µM BAPTA-AM (Calbiochem, USA), 10 µM U73122 (Calbiochem, USA), 10 µM U73343 (Calbiochem, USA), 200 µM Epac agonist (8-pCPT-2’-O-Me-cAMP, Sigma, USA), 25 µM Epac antagonist ESI-05 (Biolog, Germany), 25 µM Epac antagonist ESI-09 (Biolog, Germany) and 50 µM geranyl geranyl transferase inhibitor, GGTI 298, which disrupts Rap1 function. Merozoites were then transferred to EC buffer (5 mM KCl, 140 mM NaCl, 1 mM MgCl2, 2 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH 7.2) followed by either measurement of cytosolic cAMP and Ca2+ levels in merozoites or microneme secretion.
Measuring P. falciparum Merozoite Invasion Rates
P. falciparum merozoites isolated as described above were either mock-treated or treated with 50 µm KH7 (Calbiochem, USA), 100 µm ACTZ (Sigma, USA), 25 µM ESI-05 (Biolog, Germany) or 25 µM ESI-09 (Biolog, Germany) for 15 min at 37°C, washed with IC buffer, resuspended in EC buffer and incubated with erythrocytes in EC buffer at 37°C under mixed gas environment for 2 h to allow invasion. EC buffer was then replaced with complete RPMI. After 18–20 h of incubation in complete RPMI under mixed gas environment to allow development of ring stages, the percentage of infected erythrocytes was scored by flow cytometry to determine invasion rates, as described earlier [52] (link).
Signaling Pathway Analysis Protocol
19 (link), and Alexa Fluor 488‐conjugated anti‐rabbit IgG (H + L) was purchased from Thermo Fisher Scientific (Waltham, MA, USA).
Doxorubicin Cardiotoxicity Evaluation
8-(4-Chloro-phenylthio)-2’-O-methyladenosine-3’5’cyclic monophosphate (8-CPT), ESI-09, and ESI-05 were from Biolog Life Science Institute (Bremen, Germany). ZVAD-fmk was from Bachem (Bubendorf, Switzerland). EPAC1 specific inhibitor (R)-CE3F4 was provided by Dr Ambroise (CEA, Gif-sur-Yvette, France) (Courilleau et al., 2013 (link)).
Preparation of MK-4, H89, and ESI-05 Stock Solutions
Calcium Signaling in Rat Ventricular Myocytes
Unless otherwise stated, all chemicals were obtained from Sigma Aldrich. The selective Epac2 inhibitors, ESI-05 (35 (link), 50 (link)) and HJC0350 (14 (link)), were obtained from Biolog and Bio-techne/Tocris, respectively. The GGT-1 inhibitor, GGTI-298 (22 (link)), is the ester prodrug form of the parent compound GGTI-297 and both were obtained from Bio-techne/Tocris. In some experiments, GGTI-297 was introduced via a patch pipette during whole-cell patch-clamp recording, while GGTI-298 was added via the bathing solution. The GGT-1 inhibitor, GGTI-2147, was obtained from Calbiochem. Active Rap1 pull-down and detection kits were obtained from ThermoFisher Scientific.
Modulation of Ca2+ Signaling Pathways
Evaluation of Cellular Signaling Modulators
Excitatory Synaptic Transmission Assay
Doxorubicin Cardiotoxicity Evaluation
8-(4-Chloro-phenylthio)-2’-O-methyladenosine-3’5’cyclic monophosphate (8-CPT), ESI-09, and ESI-05 were from Biolog Life Science Institute (Bremen, Germany). ZVAD-fmk was from Bachem (Bubendorf, Switzerland). EPAC1 specific inhibitor (R)-CE3F4 was provided by Dr Ambroise (CEA, Gif-sur-Yvette, France) (Courilleau et al., 2013 (link)).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!